Author

Eric A. Hungate

University of Chicago

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Kenan OneliD· 2 shared Abrar AlharbiiD· 1 shared Adam Ivey· 1 shared Alan K. BurnettiD· 1 shared Alyssa Clay‐GilmouriD· 1 shared Amanda GilkesiD· 1 shared András MassziiD· 1 shared Andrew D. SkoliD· 1 shared

Activity by Year

2015-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Kenan OnelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

Wei‐Yu Lin, Sarah Elizabeth Fordham, Eric A. Hungate, Nicola J. Sunter, Claire J. Elstob, Yaobo Xu, Catherine Park, Anne S. Quante, Konstantin Strauch, Christian Gieger, Andrew D. Skol, Thahira Rahman, Lara E. Sucheston‐Campbell, Junke Wang, Theresa Hahn, , James M. Allan

This study identifies two genome-wide significant susceptibility loci for acute myeloid leukemia through a meta-analysis of GWAS data.

Nature Communications · Oct 29, 2021Peer-reviewedGenetic & Genomic Medicine

Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics

Yong Tao, Zheng Hu, Shaoping Ling, Shiou-Hwie Yeh, Weiwei Zhai, Ke Chen, Chunyan Li, Yu Wang, Kaile Wang, Hurng-Yi Wang, Eric A. Hungate, Kenan Onel, Jiang Liu, Changqing Zeng, Richard R. Hudson, , Chung-I Wu

The study analyzes genetic diversity in multiple hepatocellular carcinomas, finding that low-frequency mutations pre-exist and contribute to drug resistance, presenting challenges and opportunities for cancer therapeutics.

bioRxiv · Aug 25, 2015 · PreprintCancer Biology